You are here: Industry Insights > Market News > Reducing analysis time with the Thermo Scientific Nicolet Summit FTIR Spectrometer

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Erythorbic Acid (Molecular Formula:C₆H₈O₆)

Sodium Erythorbate(Molecular Formula:C₆H₇NaO₆·H₂O)

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

Reducing analysis time with the Thermo Scientific Nicolet Summit FTIR Spectrometer

europeanpharmaceuticalreview May 17, 2019

Tag: FTIR , Nicolet , spectrometer , QA/QC

Favorites

Meet the new compact FTIR spectrometer that features an innovative design and software platform to significantly improve reliability and productivity, ideal for busy QA/QC labs and teaching labs.

Cut analysis time in half with the Thermo Scientific™ Nicolet™ Summit FTIR Spectrometer. This compact spectrometer improves lab efficiency with its combination of hardware and innovative Thermo Scientific™ OMNIC™ Paradigm Software to run Smart Background collection, display visual pass/fail results on the LightBar, create libraries, and automate workflows.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

Previous:Product Hub: High-throughput experimentation made easier with Katalyst D2D

Next:Creating a modern landscape

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Reducing analysis time with the Thermo Scientific Nicolet Summit FTIR Spectrometer | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Reducing analysis time with the Thermo Scientific Nicolet Summit FTIR Spectrometer

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may like
More>>

Reducing analysis time with the Thermo Scientific Nicolet Summit FTIR Spectrometer

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>